Altimmune
ALT
ALT
143 hedge funds and large institutions have $389M invested in Altimmune in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
28% more funds holding
Funds holding: 112 → 143 (+31)
6.79% more ownership
Funds ownership: 57.53% → 64.32% (+6.8%)
Holders
143
Holding in Top 10
4
Calls
$32M
Puts
$19.3M
Top Buyers
| 1 | +$17.4M | |
| 2 | +$6.67M | |
| 3 | +$5.2M | |
| 4 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
+$3.25M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.98M |
Top Sellers
| 1 | -$7.18M | |
| 2 | -$7.15M | |
| 3 | -$3.02M | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$2.72M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.46M |